Is Jasper Therapeutics, Inc. (JSPR) a Buy, Sell, or Hold?
NASDAQ : JSPR
Jasper Therapeutics, Inc. — Analyst Ratings
$0.9522 USD
$0.15 (19.11%)
- Volume
- 1.18M
- Average Volume
- 1.14M
- Market Capitalization
- $15.48M
- P/E Ratio
- -0.28
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $3.14
- Year Low
- $0.32
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Analyst Consensus Summary
Consensus Rating
Sell
13 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-68.3%
vs Current Price
Price Target
$3.00
Average TargetPrice Target Range
Lowest Target
$3.00
-68.3% DOWNSIDE
Average Target
$3.00
Median Estimate
Highest Target
$3.00
-68.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Gregory Renza | $48 | $17.71 | 2025-01-09 06:19 AM | 171.0% |
| BMO Capital | Etzer Darout | $63 | $21.53 | 2024-12-05 04:06 PM | 192.6% |
| H.C. Wainwright | Emily Bodnar | $65 | $24.52 | 2024-05-06 02:06 AM | 165.1% |
| Evercore ISI | Gavin Clark-Gartner | $65 | $26.2 | 2024-04-03 02:38 AM | 148.1% |